Mohammad Elsayed, MD

CIO 2021-21 Y-90 Radioembolization of Unresectable High-Risk Hepatic Adenoma in a Patient With Chronic Liver Disease

Purpose: To describe the use of Y-90 radioembolization (Y-90 RE) for unresectable high risk hepatic adenoma in a patient with chronic liver disease.

Mohammad Elsayed , MD;

Morgan J. Whitmore , MD;

Mohammed F. Loya , MD;

11/15/2021

Interview

The Future of IO: Embracing the ‘Pioneer Spirit’ of Innovative Cancer Care

08/22/2023

Mohammad Elsayed , MD;

Stephen B. Solomon , MD;

The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...

The interventional oncology...

08/22/2023

IO Learning

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Mohammad Elsayed, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products